Aromatase immunoreactivity is increased in mammographically dense regions of the breast
- 209 Downloads
Mammographic breast density (MBD) is one of the strongest risk factors for breast cancer. Unfortunately, the biologic basis underlying this association is unknown. This study compared aromatase expression or immunoreactivity (IR) in core biopsies from mammographically dense versus non-dense regions of the breast to examine whether estrogen synthesis in the breast is associated with MBD and one possible mechanism through which MBD may influence breast cancer. Eligible participants were 40+ years, had a screening mammogram with visible MBD and no prior cancer or current endocrine therapy. Mammograms were used to identify dense and non-dense regions and ultrasound-guided core biopsies were performed to obtain tissue from these regions. Immunostaining for aromatase employed the streptavidin–biotin amplification method and #677 mouse monoclonal antibody. Aromatase IR was scored in terms of extent and intensity of staining for each cell type (stroma, epithelium, adipocytes) on histologic sections. A modified histological H-score provided quantitation of aromatase IR in each cell type and overall. Repeated measure analyses evaluated average differences (βH) in H-score in dense versus non-dense tissue within and across cell types. Forty-nine women with mean age 50 years (range: 40–82), participated. Aromatase IR was increased in dense (vs. non-dense) tissue in both the stroma (βH = 0.58) and epithelium (βH = 0.12) (P < 0.01). Adipocytes from non-dense tissue, however, had a greater IR compared to those from dense tissue (βH = −0.24, P < 0.01). An overall H-score which integrated results from all cell types demonstrated that aromatase IR was twice as great for dense (mean H-score = 0.90, SD = 0.53) versus non-dense (mean H-score = 0.45, SD = 0.39) breast tissue (βH = 0.45; P < 0.001). Overall, aromatase IR was greater for mammographically dense versus non-dense tissue and may partly explain how MBD influences breast cancer.
KeywordsAromatase Breast density Dense area
We thank the participants in this study, who provided samples for investigations of the determinants of breast density. This study was financially supported by the Mayo Clinic Breast SPORE, NIH CA116201; NIH K12 RR24151 for the KL2 Clinical and Translational Science Award-Mentored Career Development Program; and Friends for an Earlier Breast Cancer Test.
- 3.Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA (2005) The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol 162:826–834CrossRefPubMedGoogle Scholar
- 5.McCormack VA, Dowsett M, Folkerd E, Johnson N, Palles C, Coupland B, Holly JM, Vinnicombe SJ, Perry NM, dos Santos Silva I (2009) Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women. Breast Cancer Res 11:R38CrossRefPubMedGoogle Scholar
- 8.Dunbier AK, Anderson H, Folkerd E, Ghazoui Z, Smith IE, Ellis MJ, Dowsett M, Neoadjuvant Letrozole Study Group (2009) Expression of estrogen responsive genes in breast cancers correlates with plasma estradiol levels in postmenopausal women. Cancer Res 69:63Google Scholar
- 20.Khan QJ, Kimler BF, O’Dea AP, Zalles CM, Sharma P, Fabian CJ (2007) Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer. Breast Cancer Res 9:R35CrossRefPubMedGoogle Scholar
- 26.Zhou J, Gurates B, Yang S, Sebastian S, Bulun SE (2001) Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. Cancer Res 61:2328–2334PubMedGoogle Scholar
- 27.Bulun SE, Price TM, Aitken J, Mahendroo MS, Simpson ER (1993) A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 77:1622–1628CrossRefPubMedGoogle Scholar
- 36.Cigler T, Tu D, Yaffe MJ, Findlay B, Verma S, Johnston D, Richardson H, Hu H, Qi S, Goss PE (2009) A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women. Breast Cancer Res Treat. 2009 Dec 6 [Epub ahead of print]Google Scholar